About
Sequenta is a biotechnology company specializing in decoding the adaptive immune system to improve patient care in diseases mediated by immune cells. It commercializes its LymphoSIGHT platform for clinical use in monitoring minimal residual disease.
Explore Sequenta's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.